If approved , cagrilintide could become a first-line option in pharmacologic obesity management , especially within aesthetic settings where facial fullness, contouring, and body composition improvements are key patient goals
GLP-1 medications deplete magnesium through reduced food intake and, in users who also take metformin, through the additional depleting effect of that medication
10.1046/j.1365-2982.1997.d01-26.x 55
Immunohistochemical analysis has revealed GLP-1 R expression in the acinar and ductal epithelium of the lacrimal gland, although this expression is significantly downregulated in diabetic models
Generalized linear mixed effects models were also used to compare the low carnitine status with the normal carnitine status on the number of ASMs, where a canonical log link function was used for Poisson distributed outcome